BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buonaguro L, Petrizzo A, Tornesello ML, Buonaguro FM. Innate immunity and hepatitis C virus infection: a microarray’s view. Infect Agent Cancer. 2012;7:7. [PMID: 22448617 DOI: 10.1186/1750-9378-7-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Fierro NA, Gonzalez-Aldaco K, Torres-Valadez R, Martinez-Lopez E, Roman S, Panduro A. Immunologic, metabolic and genetic factors in hepatitis C virus infection. World J Gastroenterol 2014; 20(13): 3443-3456 [PMID: 24707127 DOI: 10.3748/wjg.v20.i13.3443] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
2 Abdo Abd Al-Hady M, Badr AA, Mostafa MA. A cognitive computational model inspired by the immune system response. Biomed Res Int 2014;2014:852181. [PMID: 25003131 DOI: 10.1155/2014/852181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Buonaguro L, Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM. Challenges in cancer vaccine development for hepatocellular carcinoma. J Hepatol. 2013;59:897-903. [PMID: 23714157 DOI: 10.1016/j.jhep.2013.05.031] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
4 Schietroma I, Scheri GC, Pinacchio C, Statzu M, Petruzziello A, Vullo V. Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals. Open Virol J. 2018;12:16-25. [PMID: 29541275 DOI: 10.2174/1874357901812010016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
5 Gómez CE, Perdiguero B, Cepeda MV, Mingorance L, García-Arriaza J, Vandermeeren A, Sorzano CÓ, Esteban M. High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome. J Virol. 2013;87:7282-7300. [PMID: 23596307 DOI: 10.1128/jvi.03246-12] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
6 Petrizzo A, Ragone C, Cavalluzzo B, Mauriello A, Manolio C, Tagliamonte M, Buonaguro L. Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy. Cancers (Basel) 2021;13:1999. [PMID: 33919186 DOI: 10.3390/cancers13091999] [Reference Citation Analysis]
7 Singh P, J FPD. A Biomolecular Network Driven Proteinic Interaction in HCV Clearance. Cell Biochem Biophys 2018;76:161-72. [PMID: 29313175 DOI: 10.1007/s12013-017-0837-y] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Obaid A, Ahmad J, Naz A, Awan FM, Paracha RZ, Tareen SH, Anjum S, Raza A, Baumbach J, Ali A. Modeling and analysis of innate immune responses induced by the host cells against hepatitis C virus infection. Integr Biol (Camb) 2015;7:544-59. [PMID: 25848650 DOI: 10.1039/c4ib00285g] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]